Better Medicines for Children, A DIA/EFGCP Conference

Plan ahead and join us to reflect on the importance of two major headways that are currently affecting Paediatric research: Innovative approaches to Drug Development and impact of the current environment on the Regulatory and Research Infrastructure

Back to Agenda

Session 5: Digital Innovation and e-Tools – Opportunities and Challenges

Session Chair(s)

Cécile Mathilde Ollivier, MS

VP Global Affairs

Critical Path Institute, Netherlands

Session 5: Digital Innovation and e-Tools – Opportunities and Challenges

Speaker(s)

Bring the Patient Experience with the Application

Alex Johnson

Duchenne UK, United Kingdom

Co-founder and Joint CEO

Ralph Bax, MD, PhD

European Medicines Agency, Netherlands

Head of the Paediatric Medicines Office

EMA Qualification Procedure: Experience from a Medtech Company

Damien Eggenspieler

SYSNAV, France

Healthcare Program Director

Digital Tools and Drug Development: an Industry Perspective

Aude Clement

F. Hoffmann-La Roche Ltd, Switzerland

Regulatory Senior Program Director

Digital Tools and Drug Development: an Industry Perspective

Invited Speaker

Switzerland

Have an account?

Better Medicines for Children, A DIA/EFGCP Conference

Session 5: Digital Innovation and e-Tools – Opportunities and Challenges

Session Chair(s)

Cécile Mathilde Ollivier, MS

Speaker(s)

Bring the Patient Experience with the Application

Ralph Bax, MD, PhD

EMA Qualification Procedure: Experience from a Medtech Company

Digital Tools and Drug Development: an Industry Perspective

Digital Tools and Drug Development: an Industry Perspective

Be informed and stay engaged.